This week ACMR is attending the Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP) from May 29 – June 1, 2018 at the Loews Miami Beach Hotel in Miami Beach, FL.
Every year over 1,200 clinicians, investigators, and research pharmacists, including competitively selected New Investigator awardees, attend this annual meeting. Federal partners such as the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the Food and Drug Administration (FDA), along with European regulatory agencies, are joining ASCP. The program emphasizes the presentation of information that has not been previously published or presented.
The 2018 ASCP Annual Meeting will discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information.
Being one of the largest independent clinical research centers in the country, ACMR is again both excited and proud to take part in such an important event that advocates for the discussion and growth of medical research.